ADIM
MRNA icon

Alpha DNA Investment Management’s Moderna MRNA Stock Holding History

Alpha DNA Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,601
Closed -$665K – 230
2024
Q2 		$665K Buy
+5,601
New +$709K 0.26% 83
2021
Q4 		– Sell
-3,958
Closed -$1.52M – 133
2021
Q3 		$1.52M Buy
+3,958
New +$1.46M 1.04% 31
2021
Q2 		– Sell
-123
Closed -$15K – 431
2021
Q1 		$15K Buy
+123
New +$17.8K 0.02% 270

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's MRNA Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 5,601 shares — an estimated $665K sold.

Alpha DNA Investment Management first reported a position in MRNA in Q1 2021 and held it in 3 quarters. The position peaked at $1.52M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,601 Moderna shares in Q3 2024, an estimated $665K.
  • Alpha DNA Investment Management first reported a position in Moderna in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's Moderna position peaked at $1.52M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.